Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

PharmScreen2

Financiado

Cerrado

Holistic Quantum Mechanics Based Platform to Accelerate Drug Discovery

Drug discovery & development projects are long processes that take approximately 15 years from the moment a molecular target is discovered to its market launch. During the past two decades, the costs of new drug development has in... ver más

31/08/2022

PHARMACELERA

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

PHARMACELERA (cnae 6202)comercio al por mayor y al por menor.distribucion comercial.importacion y exportacion.prestacion de servicios.actividades de gest...

TRL 4-5 | 264K€

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2022-08-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

PHARMACELERA

958.70K€ | Lider

ZEULAB

223.41K€ | Participante

Proyectos interesantes

PTQ-09-02-02231

Medical Technol...

Data Science

111K€ Cerrado

REMATCH

Medical Technol...

Data Science

150K€ Cerrado

UNAH13-4E-2006

Medical Technol...

Data Science

20K€ Cerrado

iDESIGN

Medical Technol...

Data Science

2M€ Cerrado

PTQ-09-02-01154

Medical Technol...

Data Science

63K€ Cerrado

PTQ-09-01-01032

Medical Technol...

Data Science

55K€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 27 meses Fecha Inicio: 2020-05-13
Fecha Fin: 2022-08-31

Líder del proyecto

PHARMACELERA (cnae 6202)comercio al por mayor y al por menor.distribucion comercial.importacion y exportacion.prestacion de servicios.actividades de gest...

TRL 4-5 | 264K€

Presupuesto del proyecto 1M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Drug discovery & development projects are long processes that take approximately 15 years from the moment a molecular target is discovered to its market launch. During the past two decades, the costs of new drug development has increased from €1 billion in 2000 to €2.58 billion in 2015. The increase is due in part to the difficulty to find New Molecular Entities (NME) subject to be patented. Computer-aided drug design (CADD) tools are used to perform virtual screening, design and the optimization of candidate molecules, but they focus in single aspects of the molecule (e.g. activity or toxicity) giving a narrow view at each development stage of the early drug discovery process, translating into expensive design cycles. The chemical space is very large and simple therapeutic areas have already been explored, therefore, the quality of the data obtained with CADD solutions is low. Only 4% of NMEs will successfully make it from the initial discovery phase to launch. To solve this problem, Pharamacelera has developed PharmScreen2, a unique and propiesoftware for drug discovery using novel molecular descriptors that enables accurate predictions of molecular properties of candidate molecules, which thereby increases the success rate of leads identification by 3x and will reduce the overall costs of drug design & development processes by 25%. PharmScreen2 is the only software that integrates the capability of performing advanced simulations of all the properties that are key in later drug discovery stages, such as activity, absorption, distribution, metabolism, toxicity (ADME-Tox) giving a holistic view. PharmScreen2 can analyse behaviors of new candidate molecules, predict the compounds’ performance in later stages and identify undesired effects early. The main objective of this project is to finalise the development of PharmScreen2, PoC with industrial partners and prepare the new PharmScreen2 from market. Pharmacelera estimates a total market size of 5.3 billion by 2023.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores